The leading event driving the future of healthcare innovation, INVEST, is coming to Chicago on April 29-30, 2025. Apply to be a speaker:
🔹 Share your expertise with top industry leaders 🔹 Network with investors, entrepreneurs, and decision-makers 🔹 Drive the conversation on the next big breakthroughs
AbbVie schizophrenia drug candidate emraclidine failed to beat a placebo in two Phase 2 clinical trials. The drug, once projected to compete with Bristol Myers Squibb's Cobenfy, is from AbbVie's $8.7 billion acquisition of Cerevel Therapeutics.
By adopting a contingent workforce model and investing in the right data tools to power better informed decision-making and talent strategy, healthcare organizations can begin to address staffing challenges and turn their talent goals into reality.
How do you know if you're spending too much or too little on EMR software? This guide from Software Advice breaks down upfront, subscription and hidden costs, plus answers other questions you've been wondering about.
No comments